Literature DB >> 17890819

Factors affecting the expression of recombinant glycoproteins.

Mercy Devasahayam1.   

Abstract

N-glycosylation is both species and tissue specific with a series of membrane bound glycosidases and glycosyltransferases modifying the oligosaccharide as it moves through the endoplasmic reticulum (ER) and Golgi. Each of these individual enzymatic reactions may not go to completion; therefore giving rise to glycoforms of the polypeptide. Glycosylation patterns of recombinant proteins are relevant for the immunogenicity, the pharmacological activity, pharmacokinetic profile, solubility and stability of the protein. This review describes the effect of primary and the 3-dimensional structure of the protein on sequon occupancy. Heterogeneity due to cell specific glycosylation and tissue culture conditions are discussed with main emphasis on N-glycosylation sequon occupancy. The review also discusses how fully glycosylated with total sequon occupancy glycoproteins which are of prime relevance in the expression of pharmaceutically relevant glycoproteins can be obtained.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890819

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  3 in total

Review 1.  Critical Factors Affecting the Success of Cloning, Expression, and Mass Production of Enzymes by Recombinant E. coli.

Authors:  Md Fakruddin; Reaz Mohammad Mazumdar; Khanjada Shahnewaj Bin Mannan; Abhijit Chowdhury; Md Nur Hossain
Journal:  ISRN Biotechnol       Date:  2012-08-13

2.  Design, construction, and expression of recombinant human interferon beta gene in CHO-s cell line using EBV-based expression system.

Authors:  Mohadeseh Shayesteh; Fahimeh Ghasemi; Fatemeh Tabandeh; Bagher Yakhchali; Mehdi Shakibaie
Journal:  Res Pharm Sci       Date:  2020-05-11

3.  Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding.

Authors:  Megan M Illick; Luis M Branco; Joseph N Fair; Kerry A Illick; Alex Matschiner; Randal Schoepp; Robert F Garry; Mary C Guttieri
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.